Oppenheimer Initiates Coverage On Kestra Medical Techs with Perform Rating
Kestra Medical Technologies Ltd KMTS
$22.83
▼ -1.38%
($-0.32)
Open
$23.38
Prev Close
$23.15
Day Range
$22.11 – $24.07
52W Range
$14.10 – $30.00
Market Cap
$1.34B
Beta
1.62
EPS (TTM)
$-2.42
📋 Company Profile
| Industry | Health Care |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2025-03-06 |
| Shares Out. | 58,600,000 |
| Phone | 14252798002 |
| Employees | 443 |
| Website | kestramedical.com ↗ |
| Revenue | $28.6M |
| Gross Profit | $15.7M |
| Net Income | -$38.8M |
| Free Cash Flow | -$116.6M |
| Total Assets | $358.5M |
| Total Liabilities | $98.8M |
| Equity | $259.7M |
About Kestra Medical Technologies Ltd
Kestra Medical Technologies Ltd is a commercial-stage wearable medical device and digital healthcare company focused on connected monitoring, therapeutic intervention, and data-driven clinical insights for cardiovascular disease. It has developed and is commercializing the Cardiac Recovery System platform, an integrated cardiac recovery ecosystem designed to support patients at elevated risk of sudden cardiac arrest (SCA) during vulnerable periods of recovery. The platform is anchored by the ASSURE Wearable Cardioverter Defibrillator (WCD), which continuously monitors patient heart rhythms and automatically delivers defibrillation therapy when life-threatening ventricular arrhythmias are detected. The platform also includes digital patient engagement and clinical workflow solutions.
Kestra Medical Technologies Ltd is a publicly traded company under the ticker symbol KMTS on the NASDAQ NMS - GLOBAL MARKET, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
13 analysts (2026-07-01)